The day Nanna exposed her bedroom secret: the lighter side of dementia
As each year ticks by, my family seeks to take over more and more aspects of my life. I’m pretty sure they think I’m losing…
Tag: Dementia
Major study on dementia risk retracted by Lancet after data bungle
An influential study suggesting hearing aid use in adults with hearing loss was linked with a reduced dementia risk has been retracted by an open-access…
Ultrasound ‘helmet’ disrupts blood-brain barrier in Alzheimer’s therapy
Temporarily disrupting the blood–brain barrier with a focused ultrasound helmet could boost the efficacy of monoclonal antibody treatments for early Alzheimer’s disease, research shows. MRI-guided…
Adult ADHD linked with threefold higher dementia risk
An ADHD diagnosis between the ages of 51 to 70 is associated with a near-threefold higher risk of dementia, a cohort study of 100,000 patients…
Chemical restraints: PBAC investigates whether mirtazapine is the new risperidone
An upcoming PBAC review of antipsychotic prescribing will consider whether risperidone restrictions in aged care are behind the increasing use of other chemical restraints. Since…
Loss of smell may precede cognition problems in Alzheimer’s patients: study
Those who carry a gene associated with Alzheimer’s disease may lose their sense of smell long before memory and thinking problems occur, a study suggests.…
Depression diagnosis at any stage of life tied to later dementia risk: study
Men and women with diagnosed depression have an increased risk for dementia, according to a study in JAMA Neurology. Dr Holly Elser, from Aarhus University…
Football headers may raise chances of later cognitive impairment
Heading the ball in soccer is associated with a higher risk for later cognitive impairment – and the risk rises with the number of headers…
Hearing aids cut rate of cognitive decline ‘only in high-risk elderly’: study
Over-70s at high risk of cognitive impairment and dementia stand to benefit the most from hearing aid intervention, US researchers report in a landmark trial.…
Alzheimer’s drug reduces plaques, slows disease progression: full results
The monoclonal antibody donanemab slows clinical progression among patients with early symptomatic Alzheimer’s disease by up to a third compared to placebo, according to a…
